Secures $3.2m in PIPE Financing -- $50m Term Sheet Obtained for Available Financing under Equity Line of Credit -BOSTON and LONDON, Nov. 14, ...

SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, today reported financial results for the quarter ended ...

Three top film screenwriters will reveal secrets behind their projects when they join Gold Derby’s special “Meet the Experts” ...

The final battle was waged last week when President-elect Donald Trump won victory. As some conservatives explain it, the ...

The European Medicines Agency has flipped its stance on Eisai and Biogen’s Alzheimer’s treatment Leqembi, recommending ...

Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind ...

Microorganisms—bacteria, viruses and other tiny life forms—may drive biological variation in visible life as much, if not ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

Bluebird bio Inc., which nine years ago was worth nearly as much as the airline JetBlue, said it's now looking for enough ...

The Eu­ro­pean Com­mis­sion is ask­ing bio­phar­ma and man­u­fac­tur­ing com­pa­nies about their re­ac­tion to No­vo ...

Gabbard has been accused of spreading Russian propaganda and former Secretary of State Hillary Rodham Clinton once referred ...

UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...